BioSpace News Archive

Sygnature Discovery has further strengthened its DMPK (drug metabolism and pharmacokinetics) capabilities, with the addition of new senior scientists to the management team.

Halo Labs Inc. (“Halo” or the “Company”) (OTCQX:AGEEF), wishes to make the following statements regarding recent market activity concerning its common shares (the “Common Shares”) traded on the OTCQX marketplace.

CytomX Therapeutics, Inc. announced that on January 15, 2020, the Company granted three new employees options to purchase a total of 44,600 shares of the Company’s common stock at an exercise price per share equal to $7.82, which was the closing trading price on January 15, 2020, the date of the grant.

Welltower Inc. (NYSE: WELL) today announced that it will release its fourth quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, February 12, 2020.

Health Canada is advising Canadians that Pharmascience Inc. is recalling one lot of PMS-Nystatin Oral Suspension, because it may contain clumps or jelly-like material that may pose a choking risk

To address needs related to Social Determinants of Health across the Inland Empire, Inland Empire Health Plan (IEHP) facilitated the development of Connect IE.

4M Institute has become the #1 Destination for Full Arch and Teeth-in-a Day training for dentists.

The American Professional Society of ADHD and Related Disorders (APSARD) is a U.S.-based international organization of health professionals and scientists focusing exclusively on ADHD and related disorders and Tris Pharma, Inc. (“Tris”), today jointly announced its multi-year, inaugural research award to advance and recognize outstanding research in the field of ADHD.

Technavio has announced its latest market research report titled global epidermolysis bullosa therapeutics market 2019-2023.

Huntington Medical Research Institutes (HMRI) announced today a $1 million, three-year award from the W. M. Keck Foundation to help support research into a deeper understanding of fluctuating sodium in the nervous system as the root cause of fluctuating brain function.